Brazilian Manufacturer Called Out for Slew of Violations By Sam | September 21, 2018 The FDA cited Brazilian OTC drugmaker Pietrobon for multiple violations including testing and equipment problems and poor recordkeeping. Source: Drug Industry Daily Posted in Drug Industry Daily